All articles by GlobalData Healthcare

  1. AstraZeneca and Daiichi Sankyo enter $6bn collaboration as pharma bets big on antibody-drug conjugates

    On July 27, AstraZeneca announced that it had entered a new global development and commercialisation agreement with Daiichi Sankyo Company…
    Read More…

    31 Jul
  2. Biden releases plans to move pharma manufacturing from China to US

    US Democratic Party presumptive presidential nominee Joe Biden plans to move a significant amount of pharmaceutical manufacturing to the US…
    Read More…

    31 Jul
  3. Lower Rate of Flu Vaccination During Pandemic Is Likely to Increase Flu Hospitalizations

    The influenza (flu) season of 2020–2021 will be different from previous years as a result of the coronavirus disease 2019…
    Read More…

    29 Jul
  4. Iran, unlike other countries, is experiencing higher fatality during second Covid-19 surge due to healthcare and welfare inequalities

    Iran is currently experiencing a second surge of Covid-19 cases since its first surge in early May. The number of…
    Read More…

    29 Jul
  5. Pregnant women with Covid-19 at greater risk for ICU admission but not mortality

    There are now more than 15 million confirmed cases of Covid-19 worldwide. The disease has reached 190 countries, with the…
    Read More…

    29 Jul
  6. Licensing agreement deals decline in the rare diseases space, experts say

    A panel of industry experts met virtually for the BIO 2020 conference this month to discuss deal-making in the rare…
    Read More…

    29 Jul
  7. AstraZeneca/Oxford University and CanSino publish promising Covid-19 vaccine clinical trial data, but too early to declare a winner

    On 20 July, AstraZeneca and Oxford University published Phase I / II results of their Covid-19 vaccine candidate ChAdOx1/AZD1222, and…
    Read More…

    29 Jul
  8. Educating both payers and patients may hold key to strong and competitive biosimilar market, say experts at BIO Conference 2020

    During the BIO Conference 2020, in the talk titled “How can the US cultivate a strong and competitive biosimilar drugs…
    Read More…

    29 Jul
  9. Report says half of US hospitals at threat of negative operating margin for rest of 2020

    The American Hospital Association (AHA) and Kaufman Hall have forecast that over half of US hospitals will be operating at…
    Read More…

    28 Jul
  10. Biotech IPO Valuation Relies on Data to Enter Capital Markets During Covid-19 Pandemic

    Biotech company initial public offering (IPO) valuations have shown resilience during the COVID-19 pandemic, compared to other industries. This is…
    Read More…

    27 Jul
Close
Close
Close

Go Top